BPA for the next generation DNA sequencing services

Ended Blanket Purchase Agreement Awarded Last action

Contract number
1333ND18ANB630002
Awardee
Awarding agency
Task orders
3 $125,530 obligated

Award facts

Opportunity
Combined order value
  • $125,530 Current, with exercised options
  • $140,115 Potential, with all options
Last date to order 100% complete
Award type
Single award
Who can order
Only the awarding agency
Set-aside
No set-aside
Pricing
Firm Fixed Price

Award details come from SAM.gov/FPDS.

About this IDV

Novogene Corporation Inc., a minority-owned small business based in Sacramento, California, was awarded a single-award Blanket Purchase Agreement by the National Institute of Standards and Technology (NIST) on July 9, 2018, for next-generation DNA sequencing services with an ultimate completion date of July 8, 2021. The BPA established a flexible contracting vehicle enabling NIST to procure advanced genomic sequencing and bioinformatics services on an as-needed basis. As a total small business set-aside, the agreement leveraged Novogene's established capabilities in comprehensive sequencing technologies, including whole genome sequencing, amplicon sequencing, transcriptome analysis, and RNA sequencing, to support NIST's scientific research initiatives. The contractor's scope encompasses DNA library preparation, sequencing service delivery, and associated bioinformatics analysis to facilitate NIST's research programs across multiple scientific domains.

Three call orders were executed under this BPA, demonstrating the agency's utilization of the vehicle for discrete research requirements. The first call order, awarded July 13, 2018, valued at $21,630.00, supported whole genome sequencing services with performance completed in Chula Vista, California by July 12, 2019. A second call order, also awarded July 13, 2018, valued at $81,665.00, provided next-generation sequencing services specifically for amplicon sequencing with performance in Chula Vista, California, concluding January 12, 2020. The third call order, awarded April 24, 2020, valued at $36,820.00, delivered DNA sequencing services with performance in Gaithersburg, Maryland, and was closed out October 14, 2022. Collectively, the three task orders totaled approximately $140,115.00, reflecting NIST's ongoing demand for sophisticated genomic sequencing capabilities to support its standards development and scientific research missions.

Task orders

Transactions

Action Obligated Date
Exercise an Option P20003 · Modification to exercise option period 2 for clin 0005 and 0006 $0
Exercise an Option P19002 · Exercising the option ordering clins 0003 and 0004 for option year 1. $0
Supplemental Agreement for work within scope P18001 · The purpose of modification P180001 is to correct language descriptions within clins 0002, 0004, 0006 and the order form to correspond with the final quote. $0
Original award $0

Quick answers

Who was awarded contract 1333ND18ANB630002?

1333ND18ANB630002 was awarded to Novogene Corporation Inc. by National Institute of Standards and Technology (Department of Commerce) on July 9, 2018.

How much is contract 1333ND18ANB630002 worth?

Orders under 1333ND18ANB630002 have obligated $125,530. Their combined potential value, with all options, is $140,115.

How many orders have been placed under contract 1333ND18ANB630002?

3 orders have been placed under 1333ND18ANB630002, the latest on April 24, 2020.

Who can order from contract 1333ND18ANB630002?

1333ND18ANB630002 is a single award blanket purchase agreement. Only the awarding agency can place orders on it.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV